O

Orpro Therapeutics

10 employees

OrPro Therapeutics develops recombinant thioredoxin for the treatment of cystic fibrosis.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Medical

Date founded

2006

Funding rounds raised

Total raised

$2.1M

from 1 investors over 1 rounds

O

Orpro Therapeutics raised $2.1M on July 19, 2022

Investors: united-states-department-of-defense

FAQ